https://www.selleckchem.com/pr....oducts/tiragolumab-a
Although C-statistics showed that NFS was the best diagnostic factor for F2 and F3, M2BPGi with NFS had an increased C-statistics value, indicating that it is a better diagnostic model. The serum M2BPGi level increased with liver fibrosis severity and could be a good biomarker for diagnosing advanced fibrosis and cirrhosis in NAFLD patients. A well-controlled, prospective study with a larger sample size is needed to validate the diagnostic power of M2BPGi and other fibrosis markers in NAFLD. The serum M2BPGi level
Gefällt mir
Kommentar
Teilen
